Private Healthcare Delivery Sector in India 2020

  • Product Code:
    RP-ID-10346834
  • Published Date:
    20 Jan 2021
  • Region:
    Global
  • Pages:
    96
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-13

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

The private healthcare delivery sector includes any healthcare services provided by an individual or group that is profitable and is not controlled or operated by the government. It plays a fundamental role in the Indian healthcare sector by serving around 79% of the urban and 72% of the rural population. In terms of revenue, the private healthcare delivery sector in India was valued at INR 11,197.43 Bn in 2019, and is estimated to reach INR 34,135.53 Bn by 2025, expanding at a CAGR of ~16.60% during the 2020 – 2025 period.
Segment insights:
The private healthcare delivery sector has three major segments – the private hospital sector, the private diagnostics sector, and the pharmacy retail sector. The private hospital sector was the largest segment, holding a market share of ~78.11% in 2019. The market share of the private diagnostics segment is estimated to increase sizeably to reach ~12.62% by 2025.
The private hospital sector has witnessed significant growth over the past few years, backed by private equity investments. The major private hospitals in India are concentrated in urban and semi-urban areas. The players in the sector are focusing on expanding their network of super-specialty and multi-specialty hospitals in tier II and tier III cities in India.
The private diagnostics sector is anticipated to exhibit a massive growth over the forecast period, on account of an increase in preventive healthcare and evidence-based treatment in India. The sector is largely fragmented and consists of hospital-based labs, standalone centers, and large diagnostic chains.
Pharmacy retail was the second-leading segment of the private healthcare delivery sector in Indian in 2019. An increase in the patient pool of those suffering from chronic illnesses, coupled with better affordability, has driven the pharmacy retail segment. With the improved digital infrastructure of the country, the online pharmacy sub-segment is expected to create immense opportunities in the market.
Impact of COVID-19:
The pandemic has had a huge impact on the private healthcare delivery sector in terms of business operations and financial performance. The enforcement of the stringent lockdown led to a steep decline in the number of patients in private hospitals, as well as diagnostic centers. The cancellation of elective surgeries and the closure of outdoor patient departments have caused a sharp decrease in industry revenue. Furthermore, travel restrictions and the closure of inter-state borders created blockages in the supply chain and logistics. However, strategies, including digital transformation, capacity expansion, and increased collaborations with vendors have improved sustainability and aided the recovery of the sector.
Companies covered:
• Apollo Hospitals Enterprise Ltd
• Dr. Lal PathLabs Ltd.
• Fortis Healthcare Ltd.
• HealthCare Global Enterprises Ltd.
• Max Healthcare Institute Ltd.
• Narayana Hrudayalaya Ltd.
• Shalby Ltd.
• Netmeds Marketplace Ltd.
• 1mg
• 91Streets Media Technologies Private Limited (PharmEasy)
Chapter 1: Executive summary

Chapter 2: Socio-economic indicators

Chapter 3: Introduction
3.1. Market definition and structure

Chapter 4: Market overview
4.1. India private healthcare delivery sector overview
4.1.1. Market size and growth forecast (2019 – 2025e)


Chapter 5: Market segmentation
5.1. Private healthcare delivery sector in India – segmentation by type
5.1.1. India private healthcare delivery sector share (%) (2019 & 2025e)
5.1.2. India private hospital market size and growth forecast (2019 – 2025e)
5.1.2.1. Private hospital sector in India – Segmentation by payer mix
5.1.3. India private diagnostics market size and growth forecast for government payer (2019 – 2025e)
5.1.3.1. Private diagnostic sector in India – Segmentation by test type
5.1.3.2. Private diagnostic sector in India – Segmentation by lab type
5.1.3.3. Private diagnostic sector in India – Segmentation by client type
5.1.3.4. Private diagnostic sector in India – Segmentation by location
5.1.4. India pharmacy retail market size and growth forecast (2019 – 2025e)
5.1.4.1. Pharmacy retail sector in India – Segmentation by retail channel
5.1.4.2. Pharmacy retail sector in India – Segmentation by drug type

Chapter 6: Impact of COVID-19
6.1. Impact on private hospital sector
6.2. Impact on private diagnostics sector
6.3. Impact on pharmacy retail sector

Chapter 7: Market influencers
7.1. Market drivers
7.2. Market challenges
Chapter 8: Market consolidation
8.1. Consolidation in private hospital sector
8.2. Consolidation in private diagnostics sector
8.3. Consolidation in pharmacy retail sector

Chapter 9.1 Competitive landscape
9.1. Apollo Hospitals Enterprise Ltd.
9.1.1. Company information
9.1.2. Business description
9.1.3. Products/Services
9.1.4. Key people
9.1.5. Financial snapshot
9.1.6. Key ratios
9.1.7. Key financial performance indicators
9.1.8. Key business segments
91.9. Key geographical segments
Note: Similar information covered for all other public companies
9.2. Dr. Lal PathLabs Ltd.
9.3. Fortis Healthcare Ltd.
9.4. HealthCare Global Enterprises Ltd.
9.5. Max Healthcare Institute Ltd.
9.6. Narayana Hrudayalaya Ltd.
9.7. Shalby Ltd.
9.8. Netmeds Marketplace Ltd.
9.9. 1mg
9.10. 91Streets Media Technologies Private Limited (PharmEasy)

Chapter 10: Recent developments
10.1. Recent developments
Chapter 11: Appendix
11.1. Research methodology
11.2. About Netscribes
11.3. Disclaimer
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
• Apollo Hospitals Enterprise Ltd.
• Dr. Lal PathLabs Ltd.
• Fortis Healthcare Ltd.
• HealthCare Global Enterprises Ltd.
• Max Healthcare Institute Ltd.
• Narayana Hrudayalaya Ltd.
• Shalby Ltd.
• Netmeds Marketplace Ltd.
• 1mg
• 91Streets Media Technologies Private Limited (PharmEasy)
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports